Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
1-15 of 474
From Evidence to Practice: Advances in Malignant Pleural Effusion Management
Clinician's RoundtableFrom Evidence to Practice: Advances in Malignant Pleural Effusion Management
Nicholas Pastis, MD
Personalized CRC Screening: Applying Real-World Evidence to Test Selection
Clinician's RoundtablePersonalized CRC Screening: Applying Real-World Evidence to Test Selection
Brian P. McDonough, MD, FAAFP
David A. Johnson, MD, FACG, FACP
Molecular Testing in Advanced Non-Small Cell Lung Cancer
On the Frontlines of Non-Small Cell Lung CancerMolecular Testing in Advanced Non-Small Cell Lung Cancer
Alexandria May, PharmD, BCPS
Timothy F. Burns, MD, PhD
Sequencing Decisions in R/R LBCL: CAR T-Cell Therapy and Bispecific Antibodies
Project Oncology®Sequencing Decisions in R/R LBCL: CAR T-Cell Therapy and Bispecific Antibodies
Steve Jackson, PharmD
Paolo F. Caimi, MD
Narendranath Epperla, MD, MS
Exploring Sub-Ablative Radiation to Modulate Immunity in Mesothelioma
Project Oncology®Exploring Sub-Ablative Radiation to Modulate Immunity in Mesothelioma
John Cho, MD, PhD, FRCPC
How ALK Vaccines Could Prolong TKI Response in mNSCLC
Project Oncology®How ALK Vaccines Could Prolong TKI Response in mNSCLC
Angel Qin, MD
- advertisement
From Durability to Discovery: Advances in ALK+ mNSCLC Treatment
Project Oncology®From Durability to Discovery: Advances in ALK+ mNSCLC Treatment
Angel Qin, MD
How Novel Strategies Could Push ALK+ mNSCLC Care Forward
Project Oncology®How Novel Strategies Could Push ALK+ mNSCLC Care Forward
Angel Qin, MD
Patterns of Progression and Resistance in ALK+ mNSCLC
Project Oncology®Patterns of Progression and Resistance in ALK+ mNSCLC
Alice T. Shaw, MD, PhD
Guiding mNSCLC Treatment After ALK-TKI Progression
Project Oncology®Guiding mNSCLC Treatment After ALK-TKI Progression
Alice T. Shaw, MD, PhD
Investigating Unanswered Questions in ALK+ mNSCLC Care
Project Oncology®Investigating Unanswered Questions in ALK+ mNSCLC Care
Alice T. Shaw, MD, PhD
Advancing Metastatic Breast Cancer Research Through Philanthropy
On the Frontlines of Metastatic Breast CancerAdvancing Metastatic Breast Cancer Research Through Philanthropy
Steve Jackson, PharmD
Ted Giovanis, FHFMA, MBA
- advertisement
Interpreting Oral SERD Trial Data in Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerInterpreting Oral SERD Trial Data in Metastatic Breast Cancer
Alexandria May, PharmD, BCPS
Donald McDonnell, PhD
Neil M. Iyengar, MD
CAR T-Cell vs Bispecific Therapies for R/R Multiple Myeloma: How They Compare
Project Oncology®CAR T-Cell vs Bispecific Therapies for R/R Multiple Myeloma: How They Compare
Charles Turck, PharmD, BCPS, BCCCP
Krina Patel, MD, MSc
Comparing CAR T-Cell Therapies for R/R Multiple Myeloma
Project Oncology®Comparing CAR T-Cell Therapies for R/R Multiple Myeloma
Charles Turck, PharmD, BCPS, BCCCP
Krina Patel, MD, MSc